Pulmonary hypertension community call - March 2022

In this call, our moderator Dr Jason Weatherald is joined by Tatiana Kudryashova, one of our PVRI Social Champions, to discuss the latest developments in PH this month. Topics include:

Noncanonical HIPPO/MST Signaling via BUB3 and FOXO Drives Pulmonary Vascular Cell Growth and Survival
BET Protein Inhibition for Pulmonary Arterial Hypertension

Articles featured in this call

https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.319100?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
file:///C:/Users/PVRI/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/0U5LRTLS/BET%20Inhibition%20in%20PAH.pdf

Sign up for news

Email address*

The PVRI requests your permission to record and use the personal information provided.

We will use your data to add you to the ‘Membership Directory’ to enable networking amongst like-minded professionals and achieve the wider goals of the PVRI, in line with our ‘Membership Agreement’ and ‘Legitimate Interests’. This directory is accessible only by other members and employees of the PVRI. Some data processing is carried out by third party suppliers, details of which can be found in our ‘Privacy Notice’ .

You can refuse or withdraw your consent at any time without detriment to your membership. You can do this by emailing admin@pvrinstitute.org.

If the purpose for which we wish to use your data or the way in which we use personal data change, we will contact you to renew consent.

Please tick here to confirm your consent to the activities listed above.

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI

Related Content

{{GlobalController.truncateTitle("Pulmonary hypertension community call - April 2022", 65)}}

{{GlobalController.truncateTitle("Ageing and pulmonary hypertension: an endemic at the horizon?", 65)}}

{{GlobalController.truncateTitle("Pulmonary hypertension community call - February 2022", 65)}}

{{GlobalController.truncateTitle("Bone marrow modulation of pulmonary vascular disease", 65)}}

{{GlobalController.truncateTitle("Pulmonary hypertension community call - January 2022", 65)}}

Add to reading list

Share this content

Our research platform is the world.